Compare · RVP vs SYK
RVP vs SYK
Side-by-side comparison of Retractable Technologies Inc. (RVP) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RVP and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $93.70B, about 518.7x RVP ($180.6M).
- Over the past year, RVP is down 10.7% and SYK is down 10.8% - RVP leads by 0.0 points.
- SYK has been more active in the news (5 items in the past 4 weeks vs 2 for RVP).
- SYK has more recent analyst coverage (25 ratings vs 0 for RVP).
- Company
- Retractable Technologies Inc.
- Stryker Corporation
- Price
- $0.65-0.62%
- $327.50-0.63%
- Market cap
- $180.6M
- $93.70B
- 1M return
- -8.30%
- -0.03%
- 1Y return
- -10.72%
- -10.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- AMEX
- NYSE
- IPO
- 2001
- News (4w)
- 2
- 5
- Recent ratings
- 0
- 25
Retractable Technologies Inc.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest RVP
- Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Retractable Technologies, Inc. Announces Workforce Reduction
- Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Retractable Technologies, Inc. Reports Results for 2025
- Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
- SEC Form 10-K filed by Retractable Technologies Inc.
- SEC Form DEFA14A filed by Retractable Technologies Inc.
- SEC Form DEF 14A filed by Retractable Technologies Inc.
- Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Latest SYK
- Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
- Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
- Leerink Partners initiated coverage on Stryker with a new price target
- Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
- Amendment: Stryker Corporation filed SEC Form 8-K: Regulation FD Disclosure
- Stryker to announce financial results for its first quarter of fiscal year 2026
- Stryker names Nick Mead Vice President, Investor Relations
- Amendment: SEC Form SCHEDULE 13G/A filed by Stryker Corporation
- SEC Form 4 filed by Stiles Spencer S
- SEC Form 4 filed by Pierce James Andrew